Bank of America Corporation »

Celldex Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.6M 218k 39.66
2023-09-30 $5.8M 212k 27.52
2023-06-30 $12M 355k 33.93
2023-03-31 $13M 362k 35.98
2022-12-31 $6.8M 153k 44.57
2022-06-30 $2.2M 82k 26.95
2021-12-31 $3.6M 94k 38.64
2021-06-30 $425k 13k 33.47
2021-03-31 $333k 16k 20.63
2020-12-31 $223k 12k 18.87
2020-09-30 $220k 15k 14.81
2020-06-30 $999 53 18.87
2020-03-31 $0 98 0.00
2019-12-31 $0 215 0.00
2019-09-30 $0 258 0.00
2019-03-31 $0 76 0.00